Oct 16, 2026
•
7 min read
A peptide that activates three hormone receptors has reached Phase 3 results. Here is how to read its weight-loss headline, the liver-fat findings, and the comparison still underway.
Oct 14, 2026
5 min read
A molecule from a fish-hunting snail reached human trials. Its path to approval explains why a powerful pain signal blocker still needs specialist care.
Oct 12, 2026
One 2026 study found no increase in a money-transfer game. Another found a 15% increase in men selected for low trust. The experiment behind each headline explains the gap.
Oct 9, 2026
6 min read
Leonard Thompson weighed 65 pounds. The first pancreatic extract brought little benefit. Twelve days later, a better preparation changed his course.
Oct 7, 2026
A seven-amino-acid peptide changed how rats behaved after two weeks of stress. The most striking result depended on a second drug.
Oct 5, 2026
3 min read
After a stroke-like injury in rats, Semax changed the activity of 394 genes. A second experiment followed the result into proteins involved in cell stress and survival.
Oct 2, 2026
In a 2021 study, two weeks of MOTS-c treatment doubled running time in old mice. The researchers also found that exercise raises this peptide in people. Its genetic instructions sit inside mitochondria.
Sep 30, 2026
A repair protein reduced damaged heart tissue by 43% in a rat experiment. TB-500 comes from a short section of that protein. Following the evidence reveals why the distinction matters.
Sep 28, 2026
9 min read
KPV reduced gut inflammation in mice and inflammatory injury in skin models. Its tiny size gives it a useful route into cells, and oral delivery adds another piece to the story.
